DACARBAZINE FOR INJECTION BP 600 MG
DACARBAZINE : 600 MG · DIN 02241445 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is DACARBAZINE FOR INJECTION BP?
DACARBAZINE FOR INJECTION BP 600 MG contains DACARBAZINE : 600 MG. It is listed in the Health Canada Drug Product Database under DIN 02241445, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 31-May-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DACARBAZINE FOR INJECTION BP used for?
Palliative therapy of metastatic malignant melanoma.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02241445 |
|---|---|
| Brand name | DACARBAZINE FOR INJECTION BP |
| Generic / active ingredient | DACARBAZINE : 600 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 600 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Prescription |
| ATC code | L01AX04 DACARBAZINE |
| AHFS class | 10:00.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-May-2017 |
| Original market date | 2000-04-04 00:00:00 |
How is it stored and handled?
The recommended storage temperature for Dacarbazine for Injection BP is between 2°C and 8°C. Protect from light.
How is it supplied?
100 mL amber glass vial containing 600 mg of dacarbazine (single-use vials).
Is DACARBAZINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code L01AX04 DACARBAZINE. 1 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DTIC DOME INJ 200MG/VIAL | 200 MG | LIQUID | MILES CANADA INC. - PHARMACEUTICAL DIVISION | CANCELLED POST MARKET | DIN 00521183 |
| DTIC-DOME -PWS IV 200MG/VIAL | 10 MG | POWDER FOR SOLUTION | BAYER INC | CANCELLED POST MARKET | DIN 02154854 |
Who else supplies DACARBAZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. DACARBAZINE appears in 14 registered pack listings across 6 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.